Faron Pharmaceuticals Oy Share Discussion Threads

[latifs100] 23/10/2018 18:25

astrazenecca should take it over

[letmepass] 23/10/2018 14:41

No money. What next

[ic0gcds00] 23/10/2018 11:44

Thats a big drop on rns

[fillipe] 23/10/2018 08:18

FARN being well bought today, right from the market open.

f

[puphead] 22/10/2018 19:23

VERY significant RNS, quote: Commenting on the results, Dr Geoff Bellingan, co-Principal Investigator of the INTEREST study, said: "... These new findings from the INTEREST study, where some patients were also given corticosteroids as part of their treatment, now suggest that we should control or exclude corticosteroids from future clinical research in ARDS patients. Corticosteroids have been shown to interfere with interferon-beta signalling(2) hence their use could block any beneficial effects of endogenous IFN-beta and may be particularly important when dosing with Traumakine. This brings fresh hope to ARDS patients as the study of Traumakine continues."Dr Matti Karvonen, Chief Medical Officer of Faron, said: "At this stage it appears possible that unexpectedly high corticosteroid use in the INTEREST trial may have masked the treatment benefit of Traumakine in ARDS patients. Therefore, the Company and the investigators await data from the ongoing Phase III ARDS trial with Japanese partner Maruishi, expected later this year, and further experimental data on lung tissue samples and YODA results, to determine the next steps for Traumakine's development."

[hashertu] 22/10/2018 18:52

I have very limited knowledge in this field, but this RNS would appear to be very significant.
Any input from someone with that knowledge would be much appreciated.

Abstract from the RNS.

Dr Marco Ranieri, co-Principal Investigator of the INTEREST study, said: "Whilst we were disappointed with the initial results from the INTEREST study, we have now made a very important observation that corticosteroid use significantly disturbs both administered and endogenous interferon-beta activity making it possibly a harmful drug in the acute phase of ARDS. This knowledge, if supported by the YODA study as well, is extremely important for ARDS patients and current practice, and it will help plan successful studies in the future for the defeat of ARDS. The concomitant use of corticosteroids and type I interferons could be prevalent in several other conditions as well (e.g. MS disease) and we believe, therefore, that the whole medical community should be more diligent with regard to their combined use."

[davidlloyd] 22/10/2018 15:52

Why such a negative reaction? Things are now moving in the right direction at last IMO.

DL

[sportbilly1976] 15/10/2018 10:02

120p resistance level under pressure...

[dave4545] 12/10/2018 10:14

People are getting desperate to make even £20 now trading

1323 paid 115 sold for 118p

All that for £20...doubt they will last long, when one position goes against them
they will lose 10 times as much

[dave4545] 12/10/2018 10:12

Can buy 7500 online

[herb clark] 12/10/2018 10:06

Can sell but not buy

[babbler] 12/10/2018 09:48

Where is all this sudden pumping coming from??

[herb clark] 12/10/2018 09:37

Can't buy any

[jobber1] 08/10/2018 20:43

Feels as though its about to warm up. Something due around the mid/end of Oct may be worth T15/T20 trade?

[dan1nat1] 08/10/2018 18:56

Fingers crossed this time, as you know it moves like a rocket so hopefully it's in the right direction...

[dan1nat1] 08/10/2018 16:35

Are you back in now bc?Looks like the build up to the 22nd is happening. I expect we will test our old friend 130 before then, time will tell if we manage to break it this time...hold tight if we do ;)

[davidlloyd] 05/10/2018 12:21

('COUGH')
DL

[jobber1] 28/9/2018 23:58

This stock has been tested at 100 and held in spite of the wide spread. Early days, but does indicate higher prices to come.

[sampsun] 21/9/2018 13:20

Such an unexciting share at mo

[dan1nat1] 19/9/2018 22:17

I didn't think UT's meant much? Happy to be corrected though.